ReviewFrontiers in endocrinology2022

Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer.

Anna E Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.